IP Library Granted Patent US 7,087,427
Granted Patent B2
US 7,087,427 · App. 09/832,292 · Granted Aug 8, 2006

Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,087,427
App. No.
09/832,292
Granted
Aug 8, 2006
Kind
B2
Abstract

The present invention provides novel mammalian alpha-kinase proteins: melanoma alpha-kinase (MK), heart alpha-kinase (HK), kidney alpha-kinase (KK), skeletal muscle alpha-kinase (SK), and lymphocyte alpha-kinase (LK). In particular, a novel kinase type is herein provided, characterized by the presence of an alpha-kinase catalytic domain and an ion channel domain. Isolated nucleic acids of the alpha-kinases MK, HK, KK, SK and LK are provided. Methods for making the novel alpha-kinases, cells that express the alpha-kinases and methods for treating an animal in need of either increased or decreased activity of the alpha-kinases are provided.

Claims (13)

1. An isolated nucleic acid encoding a mammalian alpha kinase expressed in the heart and having alpha kinase activity, wherein the nucleic acid is selected from the group consisting of:

a. the DNA sequence of SEQ ID NO: 34; and

b. DNA sequences capable of encoding the amino acid sequence encoded by the DNA sequences of subpart (a).

2. An isolated nucleic acid encoding human alpha kinase, expressed in the heart and having alpha kinase activity, wherein the nucleic acid comprises the DNA sequence of SEQ ID NO: 34.

3. A recombinant DNA expression vector comprising the nucleic acid of claim 1 , wherein the DNA encoding the alpha kinase is operatively associated with an expression control sequence.

4. An isolated transformed host cell transfected with the DNA vector of claim 3 .

5. A unicellular host transformed with a recombinant DNA molecule comprising a DNA sequence which encodes a mammalian alpha kinase selected from the group consisting of:

a. the DNA sequence of SEQ ID NO: 34;

b. DNA sequences that encoding the amino acid sequence encoded by the DNA sequence of subpart(a)and

c. a fragment of SEQ ID NO: 34 wherein said fragment has alpha kinase activity;

wherein said DNA sequence is operatively linked to an expression control sequence.

6. The unicellular host of claim 5 wherein the unicellular host is selected from the group consisting of E. coli, Pseudomonas, Bacillus, Streptomyces , yeasts, CHO, R1.1, B-W, L-M, COS 1, COS 7, BSC1, BSC40, and BMT10 cells, plant cells, insect cells, mouse cells and human cells in tissue culture.

7. An isolated nucleic acid encoding a mammalian alpha kinase comprising the amino acid sequence set out in SEQ ID NO: 35, expressed in the heart and having alpha kinase activity.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 13, 2020
From: RUTGERS, THE STATE UNIVERSITY OF N.J.
To: NIH - DEITR
Reel/Frame 051489/0054 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2014
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 033525/0369 →